BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11432822)

  • 1. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
    Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M
    EMBO J; 2001 Jul; 20(13):3342-50. PubMed ID: 11432822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
    Hospital V; Nishi E; Klagsbrun M; Cohen P; Seidah NG; Prat A
    Biochem J; 2002 Oct; 367(Pt 1):229-38. PubMed ID: 12095415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.
    Elenius K; Paul S; Allison G; Sun J; Klagsbrun M
    EMBO J; 1997 Mar; 16(6):1268-78. PubMed ID: 9135143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.
    Jin K; Mao XO; Sun Y; Xie L; Jin L; Nishi E; Klagsbrun M; Greenberg DA
    J Neurosci; 2002 Jul; 22(13):5365-73. PubMed ID: 12097488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
    Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
    Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor.
    no M; Raab G; Lau K; Abraham JA; Klagsbrun M
    J Biol Chem; 1994 Dec; 269(49):31315-21. PubMed ID: 7983076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.
    Thompson SA; Higashiyama S; Wood K; Pollitt NS; Damm D; McEnroe G; Garrick B; Ashton N; Lau K; Hancock N
    J Biol Chem; 1994 Jan; 269(4):2541-9. PubMed ID: 8300582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.
    Aviezer D; Yayon A
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12173-7. PubMed ID: 7991602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate.
    Higashiyama S; Abraham JA; Klagsbrun M
    J Cell Biol; 1993 Aug; 122(4):933-40. PubMed ID: 8349739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.
    Paria BC; Elenius K; Klagsbrun M; Dey SK
    Development; 1999 May; 126(9):1997-2005. PubMed ID: 10101133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site.
    Suzuki M; Raab G; Moses MA; Fernandez CA; Klagsbrun M
    J Biol Chem; 1997 Dec; 272(50):31730-7. PubMed ID: 9395517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
    Modjtahedi H; Dean C
    Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.
    Ushiro S; Ono M; Izumi H; Kohno K; Taniguchi N; Higashiyama S; Kuwano M
    Jpn J Cancer Res; 1996 Jan; 87(1):68-77. PubMed ID: 8609052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments.
    Besner GE; Whelton D; Crissman-Combs MA; Steffen CL; Kim GY; Brigstock DR
    Growth Factors; 1992; 7(4):289-96. PubMed ID: 1306684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.
    Zhou Z; Harding PA
    Cell Prolif; 2007 Apr; 40(2):213-30. PubMed ID: 17472728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts.
    Wang J; Mayernik L; Schultz JF; Armant DR
    Development; 2000 Jan; 127(1):33-44. PubMed ID: 10654598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
    Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR
    J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.